Marked elevation in plasma osteoprotegerin constitutes an early and consistent feature of cerebral malaria by Craig, Alister G. et al.
773Blood Cells, Inflammation and Infection
Marked elevation in plasma osteoprotegerin constitutes an early and 
consistent feature of cerebral malaria
Niamh O’Regan1*; Chris Moxon2,3*; Kristina Gegenbauer1; Jamie M. O’Sullivan1; Alain Chion1; Owen P. Smith4,5;  
Roger J. S. Preston5,6; Teresa M. Brophy1; Alister G. Craig7; James S. O’Donnell 1,8
1Haemostasis Research Group, Institute of Molecular Medicine, Trinity Centre for Health Sciences, St James’s Hospital, Trinity College Dublin, Ireland; 2Institute of Infection and 
 Global Health, University of Liverpool, UK; 3Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi; 4National 
Children’s Research Centre, Our Lady’s Children’s Hospital, Crumlin, Dublin, Ireland; 5Haematology Dept, Our Lady’s Children’s Hospital, Dublin, Ireland; 6Department of Clinical 
Medicine, School of Medicine, Trinity  College Dublin, Ireland; 7Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool, UK; 8National Centre for Hereditary 
 Coagulation Disorders, St James’s  Hospital, Dublin, Ireland
Summary
Adherence of infected erythrocytes to vascular endothelium causes 
acute endothelial cell (EC) activation during Plasmodium falciparum 
infection. Consequently, proteins stored in Weibel-Palade (WP) bodies 
within EC are secreted into the plasma. Osteoprotegerin (OPG) binds 
to VWF and consequently is stored within WP bodies. Given the critical 
role of EC activation in the pathogenesis of severe malaria, we investi-
gated plasma OPG levels in children with P. falciparum malaria. At 
presentation, plasma OPG levels were significantly elevated in 
children with cerebral malaria (CM) compared to healthy controls 
(means 16.0 vs 0.8 ng/ml; p< 0.01). Importantly, OPG levels were also 
significantly higher in children with CM who had a fatal outcome, 
compared to children with CM who survived. Finally, in children with 
CM, plasma OPG levels correlated with other established prognostic 
indices (including plasma lactate levels and peripheral parasite den-
sity). To further investigate the relationship between severe malaria 
and OPG, we utilised a murine model of experimental CM in which 
C57BL/6J mice were infected with P. berghei ANKA. Interestingly, plas-
ma OPG levels were increased 4.6 fold within 24 hours following P. 
berghei inoculation. This early marked elevation in OPG levels was ob-
served before any objective clinical signs were apparent, and preced-
ed the development of peripheral blood parasitaemia. As the mice be-
came increasingly unwell, plasma OPG levels progressively increased. 
Collectively, these data suggest that OPG constitutes a novel bio -
marker with prognostic significance in patients with severe malaria. In 
addition, further studies are required to determine whether OPG plays 
a role in modulating malaria pathogenesis.
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Introduction
Plasmodium falciparum malaria continues to be associated with 
significant morbidity and mortality (1, 2). In particular cerebral 
malaria (CM), a severe encephalopathy caused by P. falciparum in-
fection, has a mortality of 10–20 % and a high rate of neurological 
sequelae in survivors (3). Although the molecular mechanisms 
underlying the pathogenesis of CM remain poorly understood, 
previous studies have demonstrated a critical role for endothelial 
cell (EC) activation (4, 5). In particular, a number of specific EC 
surface receptors, including CD36, endothelial protein C receptor 
(EPCR), E-selectin and intercellular adhesion molecule-1 
(ICAM-1), have been shown to regulate the adhesion and seques-
tration of P. falciparum-infected erythrocytes (IE) within the 
microvasculature (6). Quantitative expression of these different EC 
surface receptors on EC surfaces is modified by inflammatory cy-
tokines, such as interleukin-1 and tumour necrosis factor (7). In 
addition to these IE surface receptors, EC also contain intracellular 
storage organelles known as Weibel-Palade (WP) bodies (8). These 
WP bodies are rod-shaped organelles that can be up to 5 µm in 
length and are specific to EC. von Willebrand factor (VWF) syn-
thesis within EC is a prerequisite for WP body formation (9, 10). 
In normal plasma, VWF circulates as a series of heterogeneous 
multimers. In contrast, VWF stored within WP bodies is enriched 
in high-molecular-weight multimers (HMWM) that demonstrate 
enhanced binding affinities for both collagen and platelets (8, 10). 
In addition, a number of other EC proteins have also been ident-
ified as WP body constituents. These include VWF propeptide 
(VWFpp), P-selectin, factor VIII, angiopoietin-2, tissue-type plas-
minogen activator (tPA), interleukin-8, galectin-3 and osteoprote-
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gerin (OPG) (8, 10). Following acute EC activation, WP bodies 
fuse with the EC surface membrane, and their contents are se-
creted directly into the plasma.
Previous studies from our laboratory and others have demon-
strated that plasma levels of HMWM VWF and VWFpp are both 
markedly elevated in patients with severe P. falciparum malaria 
(11–17). Furthermore, plasma VWF:Ag and VWFpp levels have 
also been shown to correlate with other biochemical prognostic 
markers in patients with severe malaria (14, 18). Interestingly, in a 
study of healthy volunteers infected with P. falciparum, de Mast et 
al. observed that the increase in plasma VWF:Ag and VWFpp lev-
els was evident from a very early stage following P. falciparum in-
fection (19). The molecular mechanism(s) underlying this early 
marked EC activation and WP body secretion have not been de-
fined. Nevertheless, emerging data suggest that the early release of 
WP body contents, and in particular VWF, may play a role in ma-
laria pathogenesis. We recently reported that platelet-decorated 
HMWM VWF strings on the surface of activated EC can directly 
adhere to trophozoite-stage P. falciparum IE in a shear-based assay 
(20). Thus, the rapid release of HMWM VWF multimers from WP 
bodies, which occurs at an early stage in the clinical course of P. 
falciparum infection, may provide a novel mechanism through 
which IE can adhere to activated EC surfaces.
In keeping with the marked elevated VWF and VWFpp levels 
observed in children with cerebral malaria (CM), plasma levels of 
Angiopoietin-2 (Ang-2), another protein stored within WP 
bodies, are also significantly elevated (11, 13, 21, 22). Moreover, 
higher plasma Ang-2 levels have also been associated with a worse 
clinical outcome (21–23). Osteoprotegrin (OPG) is another EC 
protein stored within WP bodies (24). OPG is recruited into WP 
bodies by binding directly to the A1 domain of VWF (24, 25). 
OPG plays a key role in regulating bone remodelling by acting as a 
soluble decoy receptor for Receptor Activator of NFκB Ligand 
(RANKL) expressed on osteoblasts (26). Recent studies have also 
identified functional roles for OPG in modulating vascular biology 
(27, 28). In particular, OPG has been shown to upregulate ex-
pression of adhesion molecules on EC surfaces, and thereby facili-
tate leucocyte adhesion (29, 30). Furthermore, OPG influences EC 
apoptosis, and elevated OPG levels have been associated with vas-
cular disease (27, 28). Given the key role of EC activation in the 
pathogenesis of severe P. falciparum malaria, we have investigated 
plasma OPG levels in children with cerebral malaria. To further 
understand the relationship between WP body secretion and ma-
laria, we have investigated OPG levels in an established murine 
model of experimental CM.
Materials and methods
Patient samples
Children aged 6 months to 12 years were recruited at Queen Eliza-
beth Central Hospital, Blantyre, Malawi between 2008 and 2011. 
Children were recruited into one of four prospectively defined 
groups: 1) CM, defined as Blantyre coma score ≤ 2, peripheral P. 
falciparum parasitaemia and an absence of clinical evidence for 
another cause of coma; 2) uncomplicated malaria, defined as an 
acute febrile illness in a child with peripheral P. falciparium parasi-
taemia and no evidence of organ compromise; 3) non-malarial 
febrile illness, defined acute febrile illness in a aparasitaemic child 
with no evidence of organ compromise and; 4) healthy controls, 
recruited from otherwise well children having elective surgery. We 
screened for parasitaemia using a rapid diagnostic test that em-
ploys a P. falicaprum specific antigen (First Response, Premier 
Medical, Kachigam, India) and if positive, peripheral parasite den-
sity was confirmed and quantified by thick and thin blood smears, 
as described previously (31). We have published data examining 
coagulation factors and soluble receptors in this cohort previously 
(31, 32), but the data presented here on VWF and OPG levels is 
presented for the first time. The study was approved by the ethical 
boards at the College of Medicine in Malawi (no. P.02/ 10/860) and 
Liverpool School of Tropical Medicine in the United Kingdom (no. 
09.74). Informed consent was obtained from the parents or legal 
guardians of all the children enrolled in this study in accordance 
with the Declaration of Helsinki.
Murine studies
Previous studies have demonstrated that wild type (WT) C57BL/6 
mice infected with P. berghei ANKA develop a complex neurologi-
cal syndrome that includes many similar clinical features (includ-
ing paralysis, seizures and coma) to those observed in patients 
with CM (33–35). Depending upon the P. berghei inoculation 
dose, mice typically die within 6 to 10 days from this experimental 
CM. Consequently we used this murine model of experimental 
CM to further investigate the relationship between severe malaria 
and OPG. All mouse experiments were performed in compliance 
with Irish Medicines Board regulations, and were reviewed and 
approved by the Trinity College Dublin BioResources Ethical 
Committee. WT C57BL/6J mice were bred in-house under stan-
dard pathogen-free conditions, and all experiments were perform-
ed on mice aged 8-10 weeks. Mice were infected by intraperitoneal 
injection of 2×106 P. berghei ANKA. Following inoculation, the 
mice were monitored using a previously validated clinical scoring 
system to assess progression of experimental CM (36). In addition, 
peripheral blood P. berghei parasitaemia levels were monitored 
daily by examination of Giemsa-stained thin blood smears ob-
tained from tail vein bleeds. Blood samples at predefined time 
points following P. berghei infection were also collected by cardiac 
puncture into acid citrate dextrose (ACD) anticoagulant (85 mM 
trisodium citrate, 65 mM citric acid, 100 mM glucose) (Sigma, Ar-
klow, Ireland). Platelet-poor plasma was prepared by centrifu-
gation of blood samples at 1500 g for 15 minutes at 20 °C. The 
samples were then aliquoted and stored at –80 °C until use.
Determination of plasma VWF:Ag and OPG levels
Human plasma VWF:Ag levels were measured using a previously 
described enzyme-linked immunosorbent assay (ELISA) (37). In 
brief, Maxisorp plates (Nunc, Roskilde, Denmark) were coated 
with rabbit anti-human VWF antibody (Dako, Glostrup, Den-
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mark) in 50 mM sodium carbonate buffer. After blocking with 3 % 
bovine serum albumin (Sigma) test samples or reference plasma 
were then added at appropriate dilutions. Bound VWF was subse-
quently detected using horseradish peroxidase–conjugated (HRP) 
rabbit anti-human VWF antibody (Dako). Following further 
washing, HRP substrate 3,3’,5,5’-Tetramethylbenzidine (TMB; 
Substrate Reagent Pack, R&D Systems, Abingdon, UK) was then 
added, and the reaction finally terminated by addition of 1 M 
H2SO4. Absorbance was read at 450 nM using a VERSAmax 
microplate reader (Molecular Devices, Winnersh, UK). Human 
and murine plasma OPG levels were determined using commer-
cial OPG ELISAs (Osteoprotegerin/TNFRSF11B DuoSet®, R&D 
Systems) performed in accordance with the manufacturer’s guide-
lines.
Statistical analysis
All experimental data and statistical analysis were performed 
using the GraphPad Prism program (Graphpad Prism version 5.0 
for Windows; GraphPad Software, Inc. San Diego, CA, USA) and 
statistical significance was assigned at a value of p< 0.05. Normally 
distributed data were expressed as mean values ± standard error of 
the mean (SEM). To assess statistical differences, data were ana-
lysed using Student’s unpaired two-tailed t-test. The Spearman 
correlation coefficient was used to determine linear association 
between different variables.
Results
Clinical characteristics
A total of 135 children with cerebral malaria, 45 children with 
non-malarial febrile illness, 52 children with uncomplicated ma-
laria and 26 healthy controls were enrolled in this study. Baseline 
clinical and laboratory characteristics are summarised in ▶ Table 
1.
Plasma VWF:Ag and OPG levels are markedly 
 elevated in children with CM
At presentation, plasma VWF:Ag levels were significantly elevated 
in Malawian children with CM compared to healthy control 
children (means 29.7 vs 8.3 µg/ml; p< 0.001) (▶ Figure 1 A). This 
~3.6 fold increase is similar in magnitude to that previously re-
ported in other cohorts of paediatric and adult patients with severe 
P. falciparum infection (12, 14–16). Plasma VWF:Ag levels were 
also mildly increased in children with uncomplicated malaria 
(UM). However the elevation in plasma VWF:Ag observed in 
children with UM was similar to that observed in children with 
other non-malarial febrile illnesses (NMFI). Plasma OPG levels 
were also markedly elevated in children with CM compared to 
healthy controls (means 16.0 vs 0.79 ng/ml; p< 0.01) (▶ Figure 
1 B). However in contrast to the 3.6-fold increase observed in 
VWF:Ag levels, plasma OPG levels were increased more than 
20-fold. Interestingly, in children with CM, plasma OPG levels var-
ied over a wide range, which may reflect that individal children 
were presenting at different times in the progression of their ma-
laria.Plasma OPG levels were also significantly elevated in children 
with UM compared to healthy controls (p< 0.05). Although plasma 
VWF:Ag levels were significantly elevated in children with NMFI, 
plasma OPG levels were not significantly increased in this cohort. 
Thus, the marked increase in OPG seems to constitute a relatively 
malaria-sensitive phenomenon. Collectively, these findings sup-
port the hypothesis that acute endothelial cell activation and WP 
body secretion constitute characteristic features of severe P. falci-
parum malaria. In addition, these data further demonstrate for the 
first time that plasma OPG levels are markedly elevated in children 
with P. falciparum.
Plasma OPG levels relate to malarial severity in 
children with P. falciparum malaria
In patients with severe P. falciparum malaria, it is well established 
that plasma lactate levels constitute a useful biochemical prog-
nostic indicator (38). Unsurprisingly, plasma lactate levels were 
Table 1: Patient characteristics and base-
line data for children enrolled. n. a. = not 
applicable; n. d. = not done. N
Age (Years)
Sex, female (%)
Mortality (%)
Temperature (˚C)
Parasitaemia (x103/µl)
Haemoglobin (g/dl)
Platelets (x103/µl)
Lactate (mmol/l)
VWF:Ag (µg/ml)
Healthy
26
5.7 ± 0.4
10 (38%)
n.a.
36.6 ± 0.1
n.d
9.9 ± 1.27
413.7 ± 102.9
2.0 ± 0.1
8.2 ± 1.0
NMFI
45
4.1 ± 0.2
27 (52%)
n.a.
38.4 ± 0.1
n.d
10.6 ± 0.2
332.5 ± 20.0
1.8 ± 0.1
24.7 ± 1.6
UM
52
5.5 ± 0.3
22 (49%)
n.a.
38.5 ± 0.1
117 ± 30
8.8 ± 0.3
140.8 ± 12.8
2.5 ± 0.1
15.4 ± 1.4
CM
135
4.2 ± 0.1
64 (47%)
20 (15%)
38.6 ± 0.1
200 ± 25
7.1 ± 0.2
102.8 ± 6.3
6.9 ± 0.3
29.7 ± 1.2
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Figure 2:  Relationship between plasma OPG levels and lactate levels 
in children with CM. A) Plasma lactate levels were performed by ELISA in 
children with CM, UM, NMFI and healthy controls. (** P< 0.01, *** 
P< 0.0001, n. s. = not significant). B) Relationship between plasma OPG lev-
els and lactate levels in children with CM. The dashed red line at 5 mmol/l de-
fines plasma lactate level considered diagnostic of lactic acidosis.
Figure 1:  Plasma VWF:Ag and OPG are markedly elevated in children 
with CM. Plasma VWF:Ag (A) and OPG levels (B) were determined by ELISA 
in children presenting with cerebral malaria (CM), uncomplicated malaria 
(UM), or non-malarial febrile illness (NMFI) as well as in a cohort of healthy 
control children. Each plasma sample was tested in duplicate at three dilu-
tions, and mean values for each group are shown. VWF:Ag and OPG levels 
were significantly elevated in children with CM compared to controls. An un-
paired Student’s t-test was performed for statistical analysis and significance 
is indicated as follows: * P< 0.05, ** P< 0.01, *** P< 0.0001, respectively.
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significantly elevated in children with CM compared to healthy 
controls (means 6.9 vs 2.0 mmol/l; p< 0.001) (▶ Figure 2 A). In ad-
dition, plasma lactate levels were significantly higher in children 
with CM compared to those with UM respectively (p< 0.001). 
Among the 135 children with confirmed CM, plasma OPG levels 
and lactate levels were significantly correlated (r=0.42, p< 0.001) 
(▶ Figure 2 B). Eighty-four children with CM demonstrated plas-
ma lactate levels greater than 5 mmol/l consistent with lactic aci-
dosis. Plasma OPG levels in children with CM and lactic acidosis 
were higher compared to levels in children with CM uncompli-
cated by lactic acidosis (means 19.6 vs 10.2; p=0.06). Importantly, 
plasma OPG levels at admission were also significantly higher in 
the 21 children with CM who later died, than in the 114 children 
with CM who survived (means 29.6 vs 14 ng/ml; p=0.026) (▶ Fig-
ure 3 A). Peripheral parasite density and platelet count have pre-
viously been defined as markers of disease severity in patients with 
severe P. falciparum. In previous studies, we found no significant 
correlation between plasma VWFpp levels and peripheral parasite 
density (14, 15). In contrast, in children with CM we observed an 
association between OPG levels and parasite density (r=0.65; 
p< 0.001) (▶ Figure 3 B). OPG levels were also negatively associ-
ated with platelet count (r= –0.5; p< 0.001) (▶ Figure 3 C).
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Plasma OPG levels are markedly elevated in 
 experimental CM
To further investigate the relationship between severe malaria and 
OPG, we utilised an established murine model of experimental 
CM. In this model, C57BL/6J mice were infected with P. berghei 
ANKA. Malaria progression was then assessed using a previously 
validated clinical scoring algorithm (36). Using this algorithm, 
overt clinical signs of malaria were first observed on Day +3 fol-
lowing P. berghei infection. Subsequently, the infected mice be-
came progressively unwell, with death typically occurring 6–7 days 
after infection (▶ Figure 4 A). Peripheral blood smear analysis 
demonstrated that P. berghei parasitaemia levels were first detect-
able 48 hours (h) following inoculation (▶ Figure 4 B). Thereafter, 
blood parasitaemia levels progressively increased as the malaria in-
fection progressed. In keeping with our findings in children with 
CM, a significant increase in plasma OPG levels was also observed 
in wild-type C57BL/6J mice following P. berghei infection (▶ Fig-
ure 4 C). For example, by Day +5 following inoculation, mean mu-
rine plasma OPG levels were increased approximately 18 fold (1.38 
ng/ml at Day 0 vs 25.5 ng/ml at Day+5; p< 0.001). This increase in 
murine plasma OPG levels seen was thus strikingly similar in 
magnitude to that observed in children with P. falciparum CM.
Interestingly, a significant increase in plasma OPG levels was 
observed from a very early stage following P. berghei infection. 
Plasma OPG levels were already increased 4.6 fold (1.38 vs 6.4 ng/
ml; p< 0.05) within 24 h following P. berghei inoculation. This early 
marked elevation in murine plasma OPG levels was established 
before any objective clinical signs were apparent (▶ Figure 4 A). 
Furthermore, the increase in plasma OPG levels also preceded the 
development of significant peripheral blood parasitaemia levels 
(▶ Figure 4 B). As the mice became increasingly unwell, plasma 
OPG levels progressively increased. Finally, and again in keeping 
with our observations in children with CM, a correlation between 
plasma OPG levels and peripheral blood parasitaemia levels was 
also observed in the murine ECM model (r=-0.9; p=0.08). Collec-
tively, these findings confirm that marked elevation in plasma 
OPG constitutes a consistent finding in both human and experi-
mental murine CM. Moreover, the increase in plasma OPG occurs 
at an early stage during the pathogenesis of severe malaria infec-
tion.
Discussion
EC activation plays a critical role in modulating the pathogenesis 
underlying severe P. falciparum malaria (4, 5). This EC activation 
triggers the secretion of WP body contents into the plasma. Pre-
vious studies have consistently shown that plasma levels of WP 
body-stored HMWM VWF are significantly increased in patients 
with both P. falciparum and P. vivax malaria (12, 14–16). Fur-
thermore, significant elevations in the plasma levels of other WP 
components (including VWFpp and Ang-2) have also been pre-
viously reported in patients with malaria infection (13, 14, 21). In 
this study, we demonstrate for the first time that severe  
Figure 3:  Plasma OPG levels relate to malaria severity in children 
with P. falciparum malaria. A) Plasma OPG levels at presentation in 
children with CM and a fatal outcome were compared to those of children 
with CM and a non-fatal outcome. B) Plasma OPG levels in children with CM 
correlated with peripheral blood P. falciparum levels. C) Plasma OPG levels 
inversely correlated with platelet count in children with CM.
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Figure 4: Marked elevation in plasma OPG levels constitutes an early 
and characteristic feature of experimental CM. WT C57BL/6J mice 
(n=12) mice were inoculated with 2 ×106 P. berghei ANKA parasites. A) Clini-
cal progression of the malaria infection was assessed were compared using a 
validated clinical scoring algorithm. Results presented illustrated represent 
the mean values ± SEM unless otherwise stated.B) Following infection with 
P. berghei, peripheral blood parasitaemia levels were determined on a daily 
basis from Giemsa-stained smears. C) Whole blood samples were collected 
from infected mice by cardiac puncture, and plasma OPG levels were then 
measured at pre-defined time points using ELISA. All ELISAs were performed 
in triplicate, and results presented represent the mean values ± SEM (* 
P< 0.05, ** P< 0.01, *** P< 0.0001, respectively).
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P. falciparum malaria is also associated with a marked increase in 
plasma OPG levels. Although the biological mechanism(s) respon-
sible for this increase in OPG have not been defined, it seems likely 
that fulminant acute endothelial cell activation is at least in part re-
sponsible. Interestingly, we observed a similar marked increase in 
plasma OPG levels in a murine model of experimental CM. In ad-
dition, using this murine model we demonstrated that the increase 
in plasma OPG develops at an early stage following malaria infec-
tion. Indeed, plasma OPG levels were significantly increased be-
fore parasitaemia was detectible, and well before the onset of any 
clinical signs. This finding is consistent with previous studies in 
which elevations in plasma VWF levels were observed at a surpris-
ingly early stage in both human volunteers infected with P. falcipa-
rum, and in mice infected with P. berghei (19).
The early and marked increase in plasma OPG levels associated 
with malaria may represent an epiphenomenon, consistent with 
acute EC activation and WP body secretion. Alternatively, it is 
possible that OPG may have a role in the pathogenesis of severe 
malaria. Although OPG has an established role in regulating os-
teoclast differentiation, more recent studies have identified addi-
tional novel biological functions. Of particular relevance, OPG has 
been shown to influence the expression of adhesion molecules on 
the EC surface, and to modulate EC apoptosis (28–30). For 
example, in vitro studies have shown that OPG increases ex-
pression of Ang-2, VCAM-1, and ICAM1 on HUVEC (29). Inter-
estingly, in this study we found significant correlations between 
plasma OPG levels and several other prognostic markers (includ-
ing plasma lactate levels, parasitaemia and thrombocytopenia) in 
children with CM. Further studies will be required to determine 
whether OPG plays any direct role in contributing to malaria pa-
thogenesis.
Notwithstanding any putative role of OPG in malaria patho-
genesis, our combined human and animal data support the hy-
pothesis that plasma OPG levels may constitute a novel biomarker 
in malaria. However, the clinical utility of changes in plasma OPG 
levels as a measure of malaria severity, or indeed as a useful diag-
nostic or prognostic clinical tool, remains to be established. In this 
context, it is interesting that although both VWF and OPG are 
stored together within WP bodies, the increase in plasma OPG 
levels in children with CM was much more marked than that in 
VWF levels. This discrepancy may relate to different relative con-
centrations of VWF and OPG being stored within WP bodies. Al-
ternatively, it is not known whether significant differences in plas-
ma half-life may exist between OPG and VWF. Finally, significant 
OPG synthesis has also been described in other non-EC tissues 
(e. g. smooth muscle cells) (39). Consequently, although WP secre-
tion is likely to be important in the aetiology of the markedly elev-
ated plasma OPG levels in severe malaria, our findings do not pre-
clude the possibility that the increased plasma OPG may also be in 
part derived from other cells. Additional studies to define the cel-
lular origins of the markedly elevated plasma OPG levels will 
therefore be of interest.
The combined increases in plasma levels of both VWF and 
OPG observed in severe malaria are of further interest in that pre-
vious studies have demonstrated that OPG can bind directly to the 
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A1 domain of VWF (24, 25). This OPG-VWF binding occurs 
within EC prior to secretion from WP bodies (25). Due to the 
ionic conditions existing in normal plasma, it seems unlikely that 
any further OPG binding to VWF takes place in the peripheral cir-
culation. Nevertheless, VWF-OPG complexes formed prior to se-
cretion from WP bodies have been shown to remain relatively 
stable in normal plasma (25). Further studies will be required to 
determine whether increased levels of this VWF-OPG complex are 
circulating in patients with severe malaria. Moreover, it remains 
unclear whether the formation of this complex has any effect upon 
the normal functional properties of either VWF and/or OPG, re-
spectively.
In conclusion, we have shown that plasma OPG levels are elev-
ated approximately 20-fold in both children with CM, and in a 
murine model of experimental CM. This marked increase in plas-
ma OPG is evident from an early stage following malaria infection. 
Furthermore, plasma OPG levels increase progressively through-
out the course of infection, and correlate with other established 
markers of outcome in patients with severe malaria. Collectively, 
these findings suggest that OPG may have a role as a novel biom-
arker in patients with severe malaria infection, and also raise the 
intriguing possibility that OPG may play a role in modulating ma-
laria pathogenesis.
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What is known about this topic?
• Acute EC activation plays a critical role in the pathogenesis of  
P. falciparum malaria. This EC activation results in release of pro-
teins stored within Weibel-Palade bodies including VWF and 
Ang-2.
• OPG binds to the A1 domain of VWF and consequently is also 
stored within the WP bodies of EC.
What does this paper add?
• Plasma OPG levels are markedly elevated in children with cer-
ebral malaria.
• Plasma OPG levels correlate with clinical severity, and inversely 
with clinical outcome, in children with severe P. falciparum ma-
laria.
• Plasma OPG levels are also markedly elevated from an early stage 
in a murine model of experimental CM.
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